| mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.9 |
| mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.9 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.0038 |
0.9 |